Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)
Clinical trial NCT01870284 · WITHDRAWN
Trial details
- NCT number
- NCT01870284
- Sponsor
- Eli Lilly and Company
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.